BAKER BROS. ADVISORS LP BioCryst Pharmaceuticals, Inc. Transaction History

BAKER BROS. ADVISORS LP portfolio value:

$160.15M
portfolio value

BAKER BROS. ADVISORS LP quarter portfolio value change:

+19.09%
quarter

BioCryst Pharmaceuticals, Inc. 13F transactions

Quarter Transaction type Change Relative change Absolute change Change value Avg. price Shares
Q3 2022 share 0.00% 0 shares 25.67M $12.6 12.71M
Q2 2022 share 0.00% 0 shares -72.19M $10.58 12.71M
Q1 2022 share 0.00% 0 shares 30.63M $16.26 12.71M
Q4 2021 share 0.00% 0 shares -6.60M $13.79 12.71M
Q3 2021 share 0.00% 0 shares -18.30M $14.37 12.71M
Q2 2021 share 0.00% 0 shares 71.68M $15.81 12.71M
Q1 2021 share Increase +0.12% 15K shares 34.68M $10.17 12.71M
Q4 2020 share 0.00% 0 shares 50.97M $7.45 12.69M
Q3 2020 share Decrease -7.78% -1.07M shares -21.98M $3.44 12.69M
Q2 2020 share Increase +25.76% 2.82M shares 43.70M $4.76 13.76M
Q1 2020 share 0.00% 0 shares -15.87M $2 10.94M
Q4 2019 share Decrease -13.98% -1.77M shares 1.30M $3.45 10.94M
Q3 2019 share Decrease -11.52% -1.65M shares -18.05M $2.87 12.72M
Q2 2019 share Decrease -4.86% -735.40K shares -68.55M $3.79 14.38M
Q1 2019 share Increase +0.10% 15K shares 1.17M $8.14 15.11M
Q4 2018 share 0.00% 0 shares 6.64M $8.07 15.10M
Q3 2018 share Increase +7.79% 1.09M shares 34.94M $7.63 15.10M
Q2 2018 share 0.00% 0 shares 13.45M $5.73 14.01M
Q1 2018 share Increase +0.11% 15K shares -1.88M $4.77 14.01M
Q4 2017 share 0.00% 0 shares -4.62M $4.91 13.99M
Q3 2017 share Increase +19.46% 2.28M shares 8.20M $5.24 13.99M
Q2 2017 share 0.00% 0 shares -33.27M $5.56 11.71M
Q1 2017 share Increase +6.87% 752.84K shares 29.01M $8.4 11.71M
Q4 2016 share 0.00% 0 shares 21.05M $6.33 10.96M
Q3 2016 share Decrease -26.96% -4.04M shares 5.72M $4.41 10.96M
Q2 2016 share 0.00% 0 shares 150K $2.84 15.01M
Q1 2016 share Increase +5.58% 792.75K shares -104.24M $2.83 15.01M